You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Merck
Express Scripts
Boehringer Ingelheim
Dow

Last Updated: February 17, 2020

DrugPatentWatch Database Preview

Actavis Elizabeth Company Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and fifteen approved drugs.

There are seven tentative approvals on ACTAVIS ELIZABETH drugs.

Summary for Actavis Elizabeth
US Patents:0
Tradenames:75
Ingredients:75
NDAs:115
Patent Litigation for Actavis Elizabeth: See patent lawsuits for Actavis Elizabeth

Drugs and US Patents for Actavis Elizabeth

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth MIRTAZAPINE mirtazapine TABLET, ORALLY DISINTEGRATING;ORAL 077959-001 Feb 14, 2011 DISCN No No   Start Trial   Start Trial
Actavis Elizabeth SPIRONOLACTONE spironolactone TABLET;ORAL 040353-002 Jul 29, 1999 DISCN No No   Start Trial   Start Trial
Actavis Elizabeth CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070976-001 Dec 16, 1986 AB RX No No   Start Trial   Start Trial
Actavis Elizabeth HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 088649-001 Oct 18, 1984 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.